Effect of O2-enriched breathing on myocardial uptake of 99mTc-sestamibi

European Journal of Nuclear Medicine

Volumn 29, Issue 11, 2002, Pages 1496-1501

  Basoglu, Tarik ^a   Yapici, Oktay ^a   Aksakal, Emre ^a   Sahin, Murathan ^a   Canbaz, Fevziye ^a   Albayrak, Selahattin ^a   Yesildag, Osman ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

99mTc sestamibi; Myocardial viability; Oxygen

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CAPTOPRIL; ISOSORBIDE 5 NITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METOPROLOL; OXYGEN; THALLIUM 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AMBIENT AIR; ANGIOCARDIOGRAPHY; ARTERIAL OXYGEN SATURATION; ARTERIAL PRESSURE; ARTICLE; CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; FEMALE; HEART MUSCLE; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; MALE; OXYGEN BREATHING; PILOT STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GATED IMAGING; HEART; METABOLISM; METHODOLOGY; MIDDLE AGED; OXYGEN THERAPY; SCINTISCANNING;

AGED; CORONARY ARTERIOSCLEROSIS; FEMALE; GATED BLOOD-POOL IMAGING; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN INHALATION THERAPY; PILOT PROJECTS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TISSUE SURVIVAL;

EID: 0036033832     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0926-y     Document Type: Article

References (23)

1. Sinusas AJ, Watson DD, Cannon JM, et al. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxy-isobutyl isonitrile and thallium-201. J Am Coll Cardiol 1989; 14:1785-1793.
2. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12:1573-1581.
3. Miron SD, Finkelhor R, Bahler R, et al. Use of Tc-99m sestamibi infusion for detection of hibernating myocardium: A preliminary report. Clin Nucl Med 1995; 20:440-445.
4. Bisi G, Sciagra R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994; 24:1282-1289.
5. Sciagra R, Pellegri M, Pupi A, et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000; 36:739-745.
6. Greco C, Ciavolella M, Tanzilli G, et al. Preoperative identification of viable myocardium: Effectiveness of nitroglycerine-induced changes in myocardial sestamibi uptake. Cardiovasc Surg 1998; 6:149-155.
7. Batista JF, Pereztol O, Valdes JA, et al. Improved detection of myocardial perfusion reversibility by rest-nitroglycerin Tc-99m-MIBI: Comparison with Tl-201 reinjection. J Nucl Cardiol 1999; 6:480-486.
8. Cameron AJV, Hutton I, Kenmure ACF, Murdoch WR. Haemodynamic and metabolic effecs of hyperbaric oxygen in myocardial infarction. Lancet 1966; 2:833-837.
9. Swift PC, Turner JH, Oxer HF, et al. Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: Comparison with exercise thallium scintigraphy. Am Heart J 1992; 5:1151-1158.
10. Smith G, Lawson D. Experimental coronary artery occlusion: Effect of administration of oxygen under pressure. Scot Med J 1958; 3:346-351.
11. Thomas MP, Brown LA, Sponseller DR, et al. Myocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator. Am Heart J 1990; 120:791-800.
12. Thurston JGB, Greenwood TW, Bending MR, et al. A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Q J Med 1973; 168:751-770.
13. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl-isonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990; 82:1826-1838.
14. Taillefer R, Tamaki N. New Radiotracers in Cardiac Imaging: Principles and Applications. Stamford, Conn.: Appleton & Lange, 1999.
15. Beanlands RSB, Dawood F, Wen WH, et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990; 82:1802-1814.
16. m-sestamibi leg scintigraphy. Nucl Med Commun 2000; 21:83-87.
17. Maublant JC, Gachon P, Moins N. Hexakis (2-methoxy isobutyl-isonitrile) technetium-99m and thallium-201 chloride: Uptake and release in cultured myocardial cells. J Nucl Med 1988; 29:48-54.
18. Meerdink DJ, Leppo JA. Comparison of hypoxia and ouabain effects on the myocardial uptake kinetics of technetium-99m hexakis 2-methoxy-isobutyl isonitrile and thallium-201. J Nucl Med 1989; 30:1500-1506.
19. Ayalew A, Marie PY, Menu M, et al. 201-Tl and 99m-Tc MIBI retention in an isolated heart model of low-flow ischemia and stunning: Evidence of negligible impact of myocyte metabolism on tracer kinetics. J Nucl Med 2002; 43:566-574.
20. Cason BA, Mickey RF, Shubayev I. Therapeutic hyperoxia diminishes myocardial stunning. J Card Surg 1994; 9:459-464.
21. Cason BA, Wisneski JA, Neese RA, et al. Effects of high arterial oxygen tension on function, blood flow distribution, and metabolism in ischemic myocardium. Circulation 1992; 85:828-838.
22. Opie LH. The Heart: Physiology, from Cell to Circulation. Philadelphia: Lippincott, Williams & Wilkins; 1998:241.
23. Kopman EA, Weygandt GR, Bauer S, Ferguson TB. Arterial hypoxemia following the administration of sublingual nitroglycerin. Am Heart J 1978; 4:444-447.